Ennio Polilli

Plain English
This study looked at a blood marker called Monocyte Distribution Width (MDW) in patients newly diagnosed with HIV to see if it could help identify individuals who are diagnosed late. Out of 97 patients examined, 63% were diagnosed late, and those with higher MDW levels had a greater chance of late diagnosis and more advanced disease. Specifically, patients with an MDW above 21.1 had more than seven times the odds of a late diagnosis. Who this helps: This research benefits patients by highlighting the importance of monitoring MDW to improve early HIV diagnosis and treatment.

Plain English
This study describes a 58-year-old man who had both neuromyelitis optica spectrum disorders (NMOSD) and mixed connective tissue disease (MCTD), which is rare and can lead to significant disability. He experienced symptoms like back pain, trouble walking, and bladder problems, and tests showed he had specific antibodies indicating these diseases. Treatment with high doses of steroids led to improvement, and follow-up MRI scans showed no further issues. Who this helps: This information is valuable for doctors treating patients who may have overlapping symptoms of neuromuscular and connective tissue disorders.

Plain English
This study looked at a measure called Monocyte Distribution Width (MDW) to see how well it can help doctors diagnose sepsis, a severe infection, in emergency rooms and intensive care units. The researchers found that MDW levels were much higher in patients with sepsis—by an average of 5.59 in the emergency room and 8.30 in the ICU. With an overall accuracy of 80% in identifying sepsis, MDW could be a valuable tool for doctors to quickly recognize this life-threatening condition, improving patient care. Who this helps: This helps patients in emergency and intensive care settings.

Plain English
This research study looked at how often two specific autoimmune conditions, Neuromyelitis Optica Spectrum Disorder (NMOSD) and Connective Tissue Diseases (CTD) like Systemic Lupus Erythematosus (SLE) and Sjogren Syndrome (SjS), occur together in patients. The findings revealed that NMOSD overlaps with SLE in 0.6% of cases and with SjS in 6.5% of cases, but this overlap increases to 26.5% among SjS patients with neurological symptoms. Understanding this relationship is important for doctors, as recognizing both conditions early can improve treatment and help prevent severe complications. Who this helps: Patients with autoimmune diseases and their healthcare providers.

Plain English
This study looked at how safe and effective a drug called dalbavancin is for treating hard-to-manage infections, particularly skin and soft tissue infections. Researchers analyzed the treatment outcomes of 100 patients and found that the overall success rate of treating these infections was between 84% and 91%. Importantly, the drug didn't cause any significant harmful side effects, making it a good option for patients with serious health issues. Who this helps: This benefits patients with difficult-to-treat infections and doctors managing their care.

Plain English
This study looked at critically ill patients with severe infections caused by tough-to-treat bacteria and assessed their immune function to predict their chances of survival. Out of 39 patients, 20 survived while 16 did not, with age and low lymphocyte counts being strong indicators of a poor outcome. Understanding these factors could help doctors provide better care for patients with these infections, potentially improving survival rates. Who this helps: This helps patients with carbapenem-resistant infections and their doctors.

Plain English
In this study, researchers looked at the health data of 431 unvaccinated COVID-19 patients in an ICU to understand what factors led to infections and deaths. They found that 44.3% of patients had blood infections (bacteremia) and 48.7% died during their stay. Key predictors for these outcomes included reactivation of certain viruses and procedures like placing patients face down (proning) and using breathing tubes, which increased the chances of infection and death. Who this helps: This research benefits doctors and healthcare providers managing severely ill COVID-19 patients.

Plain English
This study looked at a case where a woman accidentally received a drug injection into her spinal fluid instead of the intended area while being treated for low back pain. She quickly became comatose and experienced significant neurological issues, including seizures, but improved over six days, leaving her with memory loss six months later. This case highlights the serious risks of medical mistakes during pain treatment and emphasizes the need for careful administration in safe environments. Who this helps: This helps patients undergoing pain management treatments.

Plain English
This study looked at Monocyte Distribution Width (MDW) as a way to spot sepsis in patients coming into the Emergency Department. Out of 2,724 patients, 272 (10%) were found to have sepsis. The findings showed that higher MDW scores, among other factors, can significantly indicate the presence of sepsis, leading to a high accuracy in predictions (95%) for early identification, which is crucial for timely treatment. Who this helps: Patients with sepsis and healthcare providers in emergency settings.

Plain English
This study looked at how to better predict which COVID-19 patients will need more care when they arrive at the emergency department. Researchers in Italy identified key factors, such as blood test results and existing health conditions, that indicated higher risks of hospitalization or severe illness. For instance, patients with a blood marker called monocyte distribution width of 22 or higher had over four times the risk of hospitalization, while those with oxygen saturation below 95% had more than eleven times the risk of needing oxygen support. Who this helps: This helps doctors make quicker and more informed decisions for COVID-19 patients in emergency settings.

Plain English
This study looked at a 67-year-old woman with Crohn's disease who developed severe neurological symptoms, including seizures and falls, and was found to have a high level of anti-SOX-1 antibodies, usually linked to certain cancers. Despite thorough testing, no cancer was found, and her condition worsened, ultimately leading to her death from complications. These findings suggest that anti-neural antibodies might not only indicate cancer but could also complicate chronic digestive diseases like Crohn's, highlighting the need for further examination of neurological issues in these patients. Who this helps: This helps doctors and patients with chronic gastrointestinal conditions by raising awareness of potential neurological complications.

Plain English
This study looked at how certain mutations in the hepatitis C virus (HCV) affect treatment outcomes in patients with genotype 3 in Italy. Researchers analyzed 539 patients and found that 15.8% of those who hadn't been treated before had mutations related to resistance, and a significant 81.5% of patients who failed treatment displayed these mutations during follow-up. Patients with specific mutations, like Y93H and A30K, were much less likely to achieve a cure, with a success rate of only 72.2%, compared to 95.7% in those without such mutations. Who this helps: This information is valuable for doctors treating hepatitis C patients, especially those with genotype 3, as it can improve treatment strategies.

Plain English
This research looked at how certain genetic changes in the NS5A protein of the hepatitis C virus (HCV) relate to liver cancer (hepatocellular carcinoma, or HCC) in patients with cirrhosis. Out of 188 patients, 34 had HCC and the study found that specific mutations in the NS5A protein were much more common in those with HCC compared to those without (for example, the mutation M133I appeared in 20.6% of HCC patients but just 3.9% of non-HCC patients). These findings are important because they suggest that these genetic mutations might play a role in the development of liver cancer in people infected with HCV, potentially guiding future treatments and screenings. Who this helps: Patients with hepatitis C as well as doctors treating them.

Plain English
This study looked at whether certain blood cells called lymphocytes could help doctors identify septic patients who are more likely to die while in the hospital. Researchers found that lower levels of CD4 T cells in the blood were linked to a higher risk of death, with a specific cutoff of fewer than 400 cells per microliter indicating increased danger (with an odds ratio of 5.3). This information is important because it could help doctors make better decisions about which patients need more intensive care right when they arrive at the hospital. Who this helps: This helps doctors and healthcare providers in treating septic patients.

Plain English
This study looked at a new measure called Monocyte Distribution Width (MDW) to help doctors quickly identify sepsis in critically ill patients in an Intensive Care Unit (ICU). Researchers studied 211 patients, finding that among the 129 suspected of sepsis, 74 (57%) were confirmed to have it. The study revealed that an MDW score above 23.0, combined with a certain blood marker called Procalcitonin, accurately predicted sepsis 92.6% of the time, while a score of 20.0 or lower effectively ruled it out 86.4% of the time. This is important because it offers a simple way for doctors to monitor and respond to patients at risk of sepsis. Who this helps: This helps doctors and ICU patients by improving early detection of sepsis.

Plain English
This study looked at how effective and safe a low dose of tocilizumab (TCZ) is when given under the skin to patients with moderate COVID-19 pneumonia who also have high levels of inflammation. They found that TCZ significantly lowered inflammation levels and improved oxygen levels for these patients; specifically, inflammation decreased by 50% on the first day and 89% by the third day. Importantly, none of the patients treated with TCZ experienced disease progression, while 50% of those who only received standard care did. Who this helps: This research benefits patients with moderate COVID-19 pneumonia and high inflammation.

Plain English
This study looked at two tests, Monocyte Distribution Width (MDW) and Procalcitonin (PCT), to see how well they identify patients with sepsis, a severe infection. Out of 260 patients, 105 were diagnosed with sepsis, and both tests were found to be effective—MDW was linked to sepsis, showing a strong relationship with every unit increase, while PCT was also very reliable, especially at levels above 1 ng/mL. These findings are important because they suggest that adding MDW to routine blood tests could help doctors detect sepsis more quickly, potentially leading to better patient outcomes. Who this helps: This helps doctors and healthcare professionals in identifying and treating sepsis more effectively.

Plain English
This study focused on developing a surveillance system in the Abruzzo Region of Italy to track infections caused by multi-drug resistant organisms (MDROs) and to improve how antibiotics are prescribed in hospitals. The system aims to monitor MDRO cases among patients and ensure that antibiotics are used appropriately. This is important because it helps prevent the spread of infections that are hard to treat and can reduce the risk of serious health complications. Who this helps: This benefits patients, healthcare providers, and public health officials.

Plain English
This study looked at how psychological factors, particularly alexithymia (difficulty in identifying and expressing emotions), affect heart health in people with HIV. Researchers found that those with alexithymia were nearly five times more likely to have carotid plaques, which can lead to heart problems, and were also at a higher risk of having serious vascular events and death from any cause over several years. Specifically, 7.6% of participants experienced a vascular event, while 5.68% died during the study. It matters because recognizing alexithymia in HIV patients can help doctors better assess and manage their cardiovascular health. Who this helps: This helps patients with HIV and their healthcare providers.

Plain English
This research looked at a 53-year-old man with a severe, recurring infection caused by a tough-to-treat bacteria called Klebsiella pneumoniae, which can lead to serious complications like septic shock. After trying various antibiotics without success, he was treated with a new combination of medications, ceftazidime and avibactam, along with meropenem, for 16 days, which led to his complete recovery. This is significant because it suggests this treatment combination could be effective for patients with similar complicated infections, offering hope where there previously were few options. Who this helps: Patients with multidrug-resistant infections, particularly those with severe soft tissue infections.

Plain English
In this study, researchers in an Italian ICU explored how to reduce the spread of multi-drug-resistant bacteria that can complicate patient care. They implemented a comprehensive plan that included careful antibiotic use, infection monitoring, and staff education. As a result, the proportion of resistant Klebsiella pneumoniae dropped dramatically from 94% to just 6%, and overall resistance among Gram-negative bacteria decreased from 91% to 13%. Who this helps: This benefits patients in ICUs by reducing the threat of difficult-to-treat infections.

Plain English
This study looked at how effective a Web-based testing program for HIV is at identifying the virus earlier compared to traditional testing methods. The researchers found that 33% of new HIV patients were diagnosed through the online program, and those patients were less likely to present with advanced disease—only 34% had late-stage HIV compared to 62% in the standard care group, and none of the Web-based patients died, while four from standard care did. This matters because earlier diagnosis can lead to better health outcomes and prevent unnecessary deaths. Who this helps: This helps patients at risk of HIV by increasing access to early testing.

Plain English
This study looked at how common natural resistance-associated substitutions (RASs) are in different types of the Hepatitis C virus (HCV) among patients in Italy. They found that about 20.7% of the 1,445 patients had RASs that may affect treatment, with the highest rates found in specific virus strains like GT1a (45.2%) and GT1b (10.8%). These findings highlight the importance of testing for these resistance markers to choose the best treatments for patients with Hepatitis C. Who this helps: This helps doctors and Hepatitis C patients in selecting effective therapies.

Plain English
This study looked at the rate of drug resistance in HIV-1 among treatment-naive patients in Italy from 2006 to 2016. Researchers found that the prevalence of transmitted drug resistance dropped from 14.5% in 2006 to 7.3% in 2016, with significant decreases in resistance to certain drugs. This is important as lower resistance rates can lead to more effective treatment options and better health outcomes for patients. Who this helps: This benefits patients living with HIV and their healthcare providers.

Plain English
This study looked at blood cell types in critically ill patients admitted to the ICU to see if they can help predict the onset of sepsis, a severe infection. Researchers found that higher levels of a specific type of immune cell called CD19 B-cells were linked to a greater chance of developing sepsis (20.5% of high CD19 groups developed sepsis compared to 16.9% of those with lower levels). They also discovered that a higher ratio of another immune cell type, CD8 T-cells, to CD19 B-cells could significantly predict sepsis risk, meaning patients with a ratio over 2.2 had a tenfold increased risk (OR: 10.3). Who this helps: This research benefits doctors by providing them with a potentially new tool to better predict and manage sepsis in critically ill patients.

Plain English
This study focused on a young patient with a severe type of meningitis caused by a highly resistant bacteria called XDR-PA. The patient had previously been treated with standard antibiotics but developed meningitis that didn’t respond. After using high doses of two other antibiotics, ceftolozane-tazobactam and fosfomycin, the patient saw quick improvement in their condition. This finding is important because it shows that these newer antibiotic options might be effective for treating difficult infections in patients who have no other treatment choices. Who this helps: This helps patients with severe infections caused by drug-resistant bacteria.

Plain English
This study examined how different treatments for hepatitis C affect liver enzyme levels and the amount of virus in patients with advanced liver disease. Researchers found that patients using a specific type of medication called NS5A inhibitors had a faster decrease in virus levels (over 99.8% effectiveness) compared to those treated with older medications. Also, these patients had a quicker improvement in liver enzyme levels, suggesting a more effective way to clear the virus without needing to kill liver cells. Who this helps: This research benefits patients with hepatitis C and their doctors by highlighting more effective treatment options.

Plain English
This study looked at how personalizing treatment for patients with hepatitis C virus (HCV) can lead to better outcomes. Researchers found that by evaluating specific genetic factors and following international guidelines, they achieved a 100% success rate in curing HCV in 131 patients, even among those with multiple risk factors. This is important because it shows that tailored approaches can significantly improve treatment success, making it easier to manage patients with challenging cases. Who this helps: This helps patients suffering from hepatitis C, especially those with complicated cases.

Plain English
This study followed a 42-year-old man who suffered from severe injuries to his abdomen and pelvis, leading to a life-threatening infection called septic shock. Despite several surgeries and treatments over three weeks, including attempts to clear infection-causing bacteria, he continued to experience health issues, including fevers and abdominal pain. Ultimately, a successful surgery to remove infection from his colon helped him recover, but the case shows the critical need for thorough treatment plans in complex infections to ensure patient survival and recovery. Who this helps: This helps patients with severe abdominal and pelvic injuries and their doctors in managing complex infections.

Plain English
Researchers studied how common the Hepatitis C virus (HCV) is among surgical patients in the Abruzzo Region of Italy. They examined data from over 55,000 patients and found that 4.4% tested positive for HCV, with higher rates among men and older individuals. The good news is that this rate has decreased from 5.4% to 4.1% over the years from 1999 to 2014, which shows progress in controlling the virus. Who this helps: This information benefits public health officials and policymakers who can use it to allocate resources for treating HCV.

Plain English
This study looks at a serious infection in an 86-year-old patient who developed a blood infection after surgery. Researchers found the bacteria causing the infection was a type of Staphylococcus that is resistant to a common antibiotic called daptomycin, marking it as the first case reported. This finding is important because it highlights the growing problem of antibiotic resistance, especially in vulnerable groups like the elderly, after surgeries. Who this helps: This helps patients, especially older adults and those recovering from surgery.

Plain English
This study focused on testing the effectiveness of Italian clinical virology laboratories in checking for a specific gene (HLA-B*57:01) that can indicate a dangerous reaction to the drug abacavir, which is used to treat HIV. The research involved distributing samples to 10 different laboratories, and all of them correctly identified whether the samples were positive or negative for HLA-B*57:01. This is important because it shows that these laboratories can reliably and cheaply perform this vital testing, ensuring patients are safely treated with abacavir. Who this helps: Patients with HIV who may be prescribed abacavir.

Plain English
This research looked at how accurate tests for hepatitis C virus (HCV) genotypes are and what happens when they are wrong. It found that up to 15.7% of patients had incorrect genotyping, which could lead to treatments that are 15% to 40% less effective. Additionally, using the wrong treatment could significantly raise costs for healthcare providers. Who this helps: This research helps patients with hepatitis C by ensuring they receive the right treatment and improving their chances of recovery.

Plain English
Researchers in Abruzzo, Italy, studied the effectiveness of a new website that allows people at risk for HIV and other sexually transmitted infections (STIs) to get tested easily. Over 15 months, about 6,000 users visited the site, and 3,046 chose to get counseling and testing; 28 people tested positive for HIV, with 92% of them successfully connected to medical care. This approach is significant because it identified a higher rate of HIV cases (0.92%) than previously seen, demonstrating the need for accessible testing options. Who this helps: This benefits individuals at risk for HIV and healthcare providers working to diagnose and treat STIs.

Plain English
This study looked at how stress and mental health issues in pregnant women with a primary cytomegalovirus (CMV) infection can affect the likelihood of passing the virus to their newborns. Out of 276 pregnant women with CMV, it was found that those experiencing post-traumatic stress symptoms were more likely to have babies with congenital CMV disease. Specifically, the presence of these stress symptoms increased the risk of the virus being transmitted from mother to child. Who this helps: This research helps pregnant women and their healthcare providers understand the importance of managing stress during pregnancy to reduce risks to newborns.

Plain English
This study looked at the cost of HIV treatment (HAART) for over 2,000 patients in Italy to understand what influences these costs. On average, HAART costs around €9,377 per patient each year, with differences depending on the treatment site. Key factors that made costs higher included the complexity of the treatment required and lower immune system health, but there was no impact from patients' age or gender. Who this helps: This research benefits healthcare providers and policymakers working to manage HIV treatment costs.

Plain English
This study examined the bone health of HIV patients by screening them for low bone mineral density (BMD) using a special imaging test called DXA. Researchers found that nearly 20% of the patients had low BMD that would have gone undetected under current guidelines; specifically, 27% of patients experienced non-traumatic bone fractures. This is important because it highlights a gap in current screening practices, showing that many patients might be at risk for fractures without receiving timely help. Who this helps: Patients living with HIV.

Plain English
This study focused on patients with hepatitis C virus (HCV) genotype 1 to see if they could benefit from a traditional treatment called dual therapy, especially by looking at how quickly the virus levels drop within the first 48 hours of treatment. Out of 171 patients, about 75% showed a good early response while 58% achieved a lasting response. Importantly, those who had a significant drop in virus levels (over 2 logs) had a 100% chance of success, indicating that a small group of patients may still benefit from dual therapy even if they don't show an immediate strong response. Who this helps: This research helps patients with HCV genotype 1 who may still have effective treatment options available to them.

Plain English
This study looked at how well various treatments for visceral leishmaniasis (VL) worked in 166 patients over five years at 15 centers in Italy. The main finding was that 93.3% of patients responded to treatment, with nearly all immunocompetent patients (98.4%) recovering, but a lower success rate of 72% in those with HIV. It highlights that even though higher doses and longer treatment times were tested, they did not improve outcomes, stressing the need for standardized treatment practices. Who this helps: This information benefits doctors treating patients with visceral leishmaniasis, especially those with varying immune conditions.

Plain English
This study looked at a specific type of bacteria called Staphylococcus pseudintermedius ST71, which was found to form small, sticky colonies. The researchers discovered that these small colony variants (SCVs) have stable characteristics similar to another type of bacteria, Staphylococcus aureus, but with unique properties. This finding is important because it helps us understand how these bacteria behave and could impact infection treatment strategies. Who this helps: This helps doctors treating infections caused by Staphylococcus pseudintermedius, especially in pets and other animals.

Plain English
This study looked at a rare type of bacteria called mannitol-nonfermenting Staphylococcus aureus, which caused an infection in a surgical wound after a lumbar microdiscectomy, a type of back surgery. The researchers found that although this strain of bacteria is not commonly detected, it can still cause serious infections, highlighting the need for careful evaluation of bacterial cultures, even if they initially seem harmless. Identifying these unusual strains is important for proper treatment and patient care. Who this helps: This helps patients undergoing back surgery and doctors treating surgical infections.

Plain English
Researchers studied a new type of yeast called Metschnikowia that was found in the sputum of a leukemia patient in Italy. This yeast produced a distinct reddish pigment but was not a type previously recognized in medical records. The study highlights the need for further research into how such yeasts may affect human health, especially since they can be carried by people. Who this helps: This helps doctors and researchers better understand potential infections in leukemia patients.

Plain English
This study looked at a patient from Nigeria who had a severe and often deadly infection from a parasite called Strongyloides stercoralis, which can spread throughout the body especially in people with weakened immune systems like those with advanced HIV. The patient had this serious condition for two years without being properly diagnosed, highlighting the importance of recognizing and testing for this parasite in at-risk individuals. Identifying these infections early can prevent severe health issues or even death. Who this helps: This helps patients with HIV and doctors treating them.

Plain English
This study focused on a rare infection in a person who received a bone marrow transplant. Researchers found that a drug-resistant strain of Staphylococcus pseudintermedius, which typically affects animals, caused a wound infection in this patient. This is important because it highlights unexpected risks in immunocompromised patients and the potential for animal bacteria to infect humans. Who this helps: This helps patients with weakened immune systems and their doctors by raising awareness about possible infections.

Plain English
This study looked at how common resistance to the drug Etravirine (ETR) is among people who failed treatment with another type of HIV medication called NNRTIs. Out of 2,854 people studied, 1,827 adults (65%) and 32 children (82%) had at least one mutation linked to ETR resistance. The findings show that children are at a much higher risk of ETR resistance compared to adults, which matters because it highlights the need for better treatment strategies for younger patients who are not responding to existing therapies. Who this helps: This helps patients, especially children with HIV, by highlighting the need for improved treatment options.

Plain English
This research paper studied how immunoglobulins, which are proteins in the immune system, can help prevent and reduce the impact of congenital cytomegalovirus (CMV) disease in babies born to infected mothers. The findings suggest that repeated infusions of immunoglobulins can lower the transmission of CMV from mothers to their babies and lessen the severity of any disease that may occur in the fetus. This matters because it shows a possible way to protect unborn children from serious health problems caused by CMV. Who this helps: Expecting mothers who are infected with CMV and their unborn babies.

Plain English
This study looked at a rare case of infection from a type of bacteria called Streptococcus pneumoniae, which is usually linked to serious illnesses like meningitis and pneumonia. A 10-year-old boy who had surgery to remove a swollen lymph node caused by cat-scratch disease developed an infected wound, and tests revealed that the bacteria found in his wound were resistant to multiple antibiotics. This discovery is important because it shows that pneumococcus can also infect surgical wounds, which expands our understanding of how this bacteria can affect different parts of the body. Who this helps: This helps doctors understand potential infection risks in patients who have had surgery, especially those with cat-scratch disease.